Esta página foi traduzida automaticamente e a precisão da tradução não é garantida. Por favor, consulte o versão em inglês para um texto fonte.

Group-based ACT for Psychological Distress of Young People (ACT-YOUNG)

22 de maio de 2026 atualizado por: Sorlandet Hospital HF

This clinical study investigates the effectiveness of two psychological treatment formats for young people aged 16-25 with symptoms of depression, anxiety, stress, or interpersonal difficulties. The study compares group-based Acceptance and Commitment Therapy (ACT) with treatment as usual (TAU), most frequent that would be individual psychotherapy, both of which are established treatment approaches.

The study uses a randomized controlled design (RCT), in which participants are randomly assigned to one of the two treatment conditions. This allows for a systematic comparison of treatment outcomes between ACT delivered in a group format and standard individual therapy.

The ACT group intervention consists of a structured program in which participants meet regularly over a defined treatment period. The treatment focuses on processes such as psychological flexibility, acceptance of internal experiences, and engagement in actions aligned with personal values.

The individual therapy condition consists of one-to-one sessions with a clinician, following standard therapeutic practice. Treatment content and duration are tailored to the participant's clinical presentation and therapeutic needs.

Outcome measures include standardized assessments of mental health symptoms, functioning, and psychological processes. These assessments are conducted at baseline, during the treatment period, at post-treatment, and at follow-up time points. Data collected from these measures will be used to evaluate changes over time and differences between the two treatment conditions.

The primary aim of the study is to determine whether group-based ACT is as effective as, or more effective than, individual psychotherapy for young people receiving mental health services. The results are expected to contribute to improved knowledge about treatment options for this age group and inform future clinical practice.

Visão geral do estudo

Status

Recrutamento

Condições

Intervenção / Tratamento

Descrição detalhada

Background and Rationale Mental health problems among adolescents and young adults represent a significant and increasing public health concern. A substantial proportion of young people experience symptoms of depression, anxiety, and related psychological distress during a developmental period characterized by major psychological, social, and biological transitions. These challenges may interfere with identity development, educational attainment, and social functioning, with potential long-term consequences for health and well-being .

At the same time, mental health services face increasing demand and limited capacity, resulting in prolonged waiting times and restricted access to timely care. Traditional outpatient treatment is primarily delivered as individual psychotherapy, which limits the number of patients that can be treated. There is therefore a need to evaluate alternative and potentially more scalable treatment formats that can maintain or improve clinical outcomes while increasing accessibility.

Acceptance and Commitment Therapy (ACT) is a transdiagnostic behavioral intervention that aims to improve psychological functioning by enhancing psychological flexibility. The ability to act in accordance with personal values while remaining in contact with difficult internal experiences. Rather than focusing solely on symptom reduction, ACT targets core processes such as acceptance, cognitive defusion, present-moment awareness, values clarification, and committed action.

Although ACT has a substantial evidence base in adult populations, research on its effectiveness for young people remains more limited, particularly in routine clinical settings and in comparison with standard care. Group-based formats may represent an efficient way of delivering ACT, while also offering therapeutic benefits such as peer support, normalization, and shared learning. The present study addresses important gaps in the literature by evaluating a structured group-based ACT intervention tailored for young people, compared with treatment as usual (TAU), within specialized mental health services.

Study Objectives The primary objective of the study is to evaluate the effectiveness of group-based ACT compared with treatment as usual in reducing symptoms of depression and anxiety among young people aged 16-25.

Secondary objectives include:

  • Evaluating the impact of the intervention on psychological well-being, quality of life, and functional outcomes
  • Assessing whether group-based ACT leads to comparable or improved remission rates relative to TAU
  • Investigating mechanisms of change, particularly the role of psychological flexibility related to the ACT processes
  • Exploring potential moderators of treatment outcome, including demographic and clinical characteristics

Study Design

This study is a randomized controlled trial (RCT) with two parallel treatment arms:

  1. Group-based Acceptance and Commitment Therapy (ACT)
  2. Treatment as usual (TAU), typically consisting of individual psychotherapy Participants meeting eligibility criteria will be randomly allocated to one of the two conditions. The study is conducted in routine clinical settings across child/adolescent (BUP) and adult (DPS) mental health services, as well as in collaboration with primary care services, to enhance ecological validity and generalizability .

The target sample size is 212 participants, accounting for expected attrition and ensuring adequate statistical power for both outcome and process analyses .

Participants

Inclusion criteria:

Age 16-25 years Moderate symptoms of depression, score of 14 and above in the DASS 21 questionnaire

Exclusion criteria:

Severe psychiatric conditions requiring alternative treatment (e.g., psychosis, bipolar disorder) Active substance dependence Acute suicidal ideation or behavior Eating disorders or developmental disorders requiring specialized interventions Participants with specific disorders for which established evidence-based treatments are indicated (e.g., OCD) will be offered those treatments outside the study.

Interventions:

Group-based ACT

The experimental intervention is a structured group program based on Acceptance and Commitment Therapy, adapted for young people using the DNA-V framework. The intervention focuses on developing skills in:

  • Awareness of internal experiences
  • Acceptance and willingness
  • Cognitive defusion
  • Values clarification
  • Committed action The group format aims to promote experiential learning and peer interaction. The intervention consists of multiple sessions delivered over a defined treatment period, with each group including up to 10 participants and led by trained therapists. Sessions are manualized to ensure consistency and fidelity, and adherence will be monitored through supervision and video recordings .

Treatment as Usual (TAU) Participants allocated to TAU will receive standard care within mental health services. This typically involves individual psychotherapy delivered by a clinician. The content, frequency, and duration of treatment are determined by clinical needs and routine practice, reflecting real-world conditions.

Procedures and Assessments:

Participants will undergo a baseline assessment prior to randomization, including diagnostic evaluation using structured clinical interviews. Follow-up assessments will be conducted at multiple time points:

  • Baseline (pre-treatment)
  • During treatment (6 weeks)
  • Post-treatment (12 weeks)
  • 6-month follow-up
  • 12-month follow-up

Outcome data will be collected using a combination of clinician-administered interviews and validated self-report measures assessing:

  • Depression and anxiety symptoms
  • General psychological distress
  • Quality of life
  • Functional impairment
  • Psychological processes relevant to ACT (e.g., flexibility, mindfulness, values-based action) In addition to these scheduled assessments, ecological momentary assessment (EMA) will be conducted using a digital platform. Participants will complete brief daily measures during the treatment period and periodic follow-up assessments thereafter. This approach allows for detailed analysis of temporal changes and treatment processes in real-world contexts .

Outcomes

Primary outcomes:

• Changes in symptoms of depression and anxiety

Secondary outcomes:

  • Psychological well-being
  • Quality of life
  • Functional impairment
  • Remission rates

Process outcomes:

  • Psychological flexibility
  • Emotional regulation
  • Mindfulness
  • Self-compassion
  • Values-consistent behavior

Statistical Analysis Data will be analyzed using appropriate statistical methods for longitudinal and randomized designs. Primary analyses will compare changes in outcome measures between treatment conditions over time.

Secondary analyses will examine:

  • Mediation effects to identify mechanisms of change
  • Moderation effects to identify subgroups for whom the treatment is particularly effective Missing data will be handled using established statistical techniques appropriate for repeated measures designs.

Ethical Considerations Participation in the study is voluntary, and all participants will provide informed consent prior to inclusion. Participants may withdraw at any time without consequences for their access to treatment.

The interventions evaluated in this study are based on established therapeutic approaches and are not expected to pose significant risk. However, participation in group-based treatment may be experienced as challenging for some individuals. Measures are in place to monitor and address adverse reactions, including the presence of trained therapists and access to follow-up support .

The study will be conducted in accordance with ethical guidelines and has been approved by the regional ethics committee.

Significance This study will contribute to the evidencebase for psychological treatments for young people by evaluating a scalable, group-based intervention within routine clinical practice. The findings may inform service development and improve access to effective mental health care for this population. Additionally, the study will provide insight into the mechanisms underlying therapeutic change, supporting further refinement of interventions based on ACT principles.

Tipo de estudo

Intervencional

Inscrição (Estimado)

212

Estágio

  • Não aplicável

Contactos e Locais

Esta seção fornece os detalhes de contato para aqueles que conduzem o estudo e informações sobre onde este estudo está sendo realizado.

Contato de estudo

Locais de estudo

    • Agder
      • Arendal, Agder, Noruega, 4824
        • Recrutamento
        • Sørlandet hospital
        • Contato:
      • Kristiansand, Agder, Noruega, 4624
        • Recrutamento
        • Sorlandet hospital
        • Contato:

Critérios de participação

Os pesquisadores procuram pessoas que se encaixem em uma determinada descrição, chamada de critérios de elegibilidade. Alguns exemplos desses critérios são a condição geral de saúde de uma pessoa ou tratamentos anteriores.

Critérios de elegibilidade

Idades elegíveis para estudo

  • Filho
  • Adulto

Aceita Voluntários Saudáveis

Não

Descrição

Inclusion Criteria:

  • Score on DASS-21 depression scale ≤ 14

Exclusion Criteria:

  • Psychosis

Plano de estudo

Esta seção fornece detalhes do plano de estudo, incluindo como o estudo é projetado e o que o estudo está medindo.

Como o estudo é projetado?

Detalhes do projeto

  • Finalidade Principal: Tratamento
  • Alocação: Randomizado
  • Modelo Intervencional: Atribuição Paralela
  • Mascaramento: Solteiro

Armas e Intervenções

Grupo de Participantes / Braço
Intervenção / Tratamento
Experimental: Group based Acceptance and Commitment Therapy
Participants assigned to this arm will receive a structured, manualized group-based Acceptance and Commitment Therapy (ACT) intervention delivered by trained clinicians.
Group-Based Acceptance and Commitment Therapy (ACT) consists of a structured, manualized group intervention delivered according to established ACT principles and tailored for young people. The intervention is provided in a group format within specialized mental health services and focuses on enhancing psychological flexibility through core ACT processes. Treatment is delivered by trained clinicians, and the group format emphasizes experiential exercises, mindfulness practices, values-based work, and peer interaction. The frequency and duration of sessions follow the study protocol.
Comparador Ativo: Treatment as usual TAU
Participants assigned to this arm will receive treatment as usual consisting of standard mental health care delivered according to routine clinical practice within hospital-based specialized mental health services and, when applicable, municipal health services or student health services. The type, format, frequency, and duration of care are determined by clinical need and may vary between participants.
Treatment as Usual (TAU) consists of standard mental health care provided according to routine clinical practice within hospital-based specialized mental health services, as well as through municipal health services and student health services when applicable. The type, format (e.g., individual or group-based), frequency, and duration of care are determined by clinical need and may vary between participants.

O que o estudo está medindo?

Medidas de resultados primários

Medida de resultado
Descrição da medida
Prazo
Depression, Anxiety, Stress Scale
Prazo: From enrollment to 1 year
Measures depression, anxiety and stress
From enrollment to 1 year
Hamilton Rating Scale Depression HDRS
Prazo: From enrollment to 1 year
Measures level of depression
From enrollment to 1 year
The Psychological Flexibility Questionnaire PSY-Flex
Prazo: From enrollment to 1 year
Questionnaire measuring Psychological Flexibility
From enrollment to 1 year

Medidas de resultados secundários

Medida de resultado
Descrição da medida
Prazo
The Structural Clinical Interview for DSM-5 Clinician Version (SCID-5-CV
Prazo: Enrollemnt of study and after 12 months
Diagnostic interview SCID 5 CV
Enrollemnt of study and after 12 months
Clinical Outcomes in Routine Evaluation (CORE-OM)
Prazo: From enrollment to 1 year
Self report about psychological symptoms
From enrollment to 1 year
The PTSD Checklist for DSM-5 PCL-5
Prazo: From enrollment to 1 year
PCL-5 questionnaire, symptoms of PTSD
From enrollment to 1 year
The Level of Personality Functioning Scale brief, LPFS-BF2.0
Prazo: From enrollment to 1 year
The Level of Personality Functioning Scale brief form, Alternative Model for Personality disorders DSM-5, section iii LPFS-BF2.0 questionnaire. Screening tool for personality disorders
From enrollment to 1 year
The Mental Health Continuum short form MHC-SF
Prazo: From enrollment to 1 year
questionnaire that measure positive mental health and well-being
From enrollment to 1 year
Alcohol Use Disorder Identification Test, AUDIT
Prazo: From enrollment to 1 year
Questionnaire screening for alcohol harmful use and dependence
From enrollment to 1 year
The drug use disorders identification test DUDIT
Prazo: From enrollment to 1 year
Questionnaire screening for harmful use and dependence of drugs
From enrollment to 1 year
Difficulties in Emotion Regulation Scale short form DERS SF
Prazo: From enrollment to 1 year
Questionnaire measuring problems with emotion regulations
From enrollment to 1 year
The Cognitive Fusion Questionnaire CFQ
Prazo: From enrollment to 1 year
Questionnaire about cognitive fusion. Cognitive fusion refers to becoming so entangled with thoughts that they strongly dominate behavior, emotions, and perception.
From enrollment to 1 year
The Bulls Eyes Values Survey scale BEVS
Prazo: From enrollment to 1 year
Questionnaire about value congruent behavior. Examening peoples values and how much they are satisfied with reaching those values
From enrollment to 1 year
The Process-Based Assessment Tool PBAT
Prazo: From enrollment to 1 year
Questionnaire measuring processes and clinical interventions in therapy
From enrollment to 1 year
The Five Facet Mindfulness Questionnaire FFMQ
Prazo: From enrollment to 1 year
Questionnaire measuring components and structure of mindfulness
From enrollment to 1 year
The Self Compassion Scale short form SCS SF
Prazo: From enrollment to 1 year
Questionnaire measuring self compassion. Measures of how compassionately a person relates to themselves during periods of difficulty, failure, suffering, or inadequacy.
From enrollment to 1 year
EQ-5D-5L
Prazo: From enrollment to 1 year
EQ EuroQol 5 D 5 Dimensions 5L 5 Levels. Questionnaire used to measure health-related quality of life (HRQoL).
From enrollment to 1 year
The Work and Social Adjustment Scale, WSAS
Prazo: From enrollment to 1 year
Questionnaire that measures how much a person's mental or physical health problems are interfering with their ability to function in everyday life
From enrollment to 1 year
The Bergen Insomnia Scale, BIS
Prazo: From enrollment to 1 year
Questionnaire for measuring insomnia
From enrollment to 1 year
The metacognitions questionnaire, MCQ-30
Prazo: From enrollment to 1 year
Questionnaire about metacognitive beliefs. The beliefs people have about their own thinking
From enrollment to 1 year

Colaboradores e Investigadores

É aqui que você encontrará pessoas e organizações envolvidas com este estudo.

Patrocinador

Colaboradores

Publicações e links úteis

A pessoa responsável por inserir informações sobre o estudo fornece voluntariamente essas publicações. Estes podem ser sobre qualquer coisa relacionada ao estudo.

Publicações Gerais

Datas de registro do estudo

Essas datas acompanham o progresso do registro do estudo e os envios de resumo dos resultados para ClinicalTrials.gov. Os registros do estudo e os resultados relatados são revisados ​​pela National Library of Medicine (NLM) para garantir que atendam aos padrões específicos de controle de qualidade antes de serem publicados no site público.

Datas Principais do Estudo

Início do estudo (Real)

9 de março de 2026

Conclusão Primária (Estimado)

31 de dezembro de 2028

Conclusão do estudo (Estimado)

31 de dezembro de 2028

Datas de inscrição no estudo

Enviado pela primeira vez

22 de maio de 2026

Enviado pela primeira vez que atendeu aos critérios de CQ

22 de maio de 2026

Primeira postagem (Real)

1 de junho de 2026

Atualizações de registro de estudo

Última Atualização Postada (Real)

1 de junho de 2026

Última atualização enviada que atendeu aos critérios de controle de qualidade

22 de maio de 2026

Última verificação

1 de maio de 2026

Mais Informações

Termos relacionados a este estudo

Outros números de identificação do estudo

  • 162090

Plano para dados de participantes individuais (IPD)

Planeja compartilhar dados de participantes individuais (IPD)?

NÃO

Informações sobre medicamentos e dispositivos, documentos de estudo

Estuda um medicamento regulamentado pela FDA dos EUA

Não

Estuda um produto de dispositivo regulamentado pela FDA dos EUA

Não

Essas informações foram obtidas diretamente do site clinicaltrials.gov sem nenhuma alteração. Se você tiver alguma solicitação para alterar, remover ou atualizar os detalhes do seu estudo, entre em contato com register@clinicaltrials.gov. Assim que uma alteração for implementada em clinicaltrials.gov, ela também será atualizada automaticamente em nosso site .